Drug profile · INN
characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins
CHONDROCELECT
- Patents linked
- 0
- News articles
- 0
Quick answer
characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins (CHONDROCELECT) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins
Brand CHONDROCELECT
ATC code M09AX02
Frequently asked questions
What is characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins?
characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins (CHONDROCELECT) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins?
CHONDROCELECT is a marketed brand name for characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins. Check FDA Drugs@FDA for the current US label holder and prescribing information.